Buscar
KORU Medical Systems Inc
KRMDAñadir a la lista de seguimiento
4.110USD
0.0000.00%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
188.78MCap. mercado
PérdidaP/E TTM
Más Datos de KORU Medical Systems Inc Compañía
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Información de KORU Medical Systems Inc
Símbolo de cotizaciónKRMD
Nombre de la empresaKORU Medical Systems Inc
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoTharby (Linda M)
Número de empleados80
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección100 Corporate Drive
CiudadMAHWAH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07430
Teléfono18454692042
Sitio Webhttps://www.korumedical.com/
Símbolo de cotizaciónKRMD
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoTharby (Linda M)
Ejecutivos de KORU Medical Systems Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
51.31K
+6.96%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de KORU Medical Systems Inc?
Los cinco principales accionistas de KORU Medical Systems Inc son: Ms. Linda M. Tharby
¿Cuántas instituciones poseen acciones de KORU Medical Systems Inc (KRMD)?
A fecha de 2026Q1, 188 instituciones poseen acciones de KORU Medical Systems Inc, con un valor de mercado combinado de aproximadamente 28.85M, lo que representa el 62.71% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -129292.00.
¿Cuál es la mayor fuente de ganancias de KORU Medical Systems Inc?
El 2026Q1, el segmento empresarial Domestic Core generó la ganancia más alta para KORU Medical Systems Inc, ascendiendo a 27.99M y representando el 68.06% de la ganancia total.